SASH1 and cancer: Based on its association with favourable prognosis in multiple human malignancies [2–8, 19] and adverse effects on cancer cell line viability and invasiveness in vitro [3, 6–8], SASH1 has been proposed as a tumour suppressor [2–4, 6, 8, 14, 20, 21].